Quality of Life Gain Following Treatment Among Breast Cancer Survivors With and Without HIV
HIV infection did not impede QOL gain at 24 months after treatment in women surviving breast cancer. Further work is needed to clarify the role of HIV on specific treatment-related morbidities and in other malignancies.
Authors
- Yehoda M. Martei (ORCID: https://orcid.org/0000-0002-5631-1567)
- Peter Vuylsteke (ORCID: https://orcid.org/0000-0001-6401-3722)
- Memory Bvochora‐Nsingo
- Neo Tapela (ORCID: https://orcid.org/0000-0002-2048-3973)
- Jason A. Efstathiou (ORCID: https://orcid.org/0000-0003-0996-0350)
- Scott Dryden‐Peterson (ORCID: https://orcid.org/0000-0002-8487-9731)
- Kutlo Manyake
- Katrin S. Sadigh (ORCID: https://orcid.org/0000-0002-4869-1061)
- James R. Wester (ORCID: https://orcid.org/0000-0002-9607-8982)
- Michael Dykstra (ORCID: https://orcid.org/0000-0003-0834-7669)
- Isaac Nkele
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of Botswana (BW)
- University of Michigan (US)
- Massachusetts General Hospital (US)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Botswana Harvard AIDS Institute Partnership (BW)
- University of Pennsylvania (US)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1200/go.24.00110
- Citations
- 2
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.57